Shao-Hsiang Shih was appointed as Chairman of the Board at VITASPRING BIOMEDICAL CO. LTD..
“Effective at 11:57 p.m. Pacific Time on September 7, 2026, Mr. Shih was appointed Chairman of the Board, to serve at the pleasure of the Board.”
VITASPRING BIOMEDICAL CO. LTD. — fact timeline
Source-grounded facts extracted from VITASPRING BIOMEDICAL CO. LTD.'s SEC 8-K filings across all families, newest first. Each cites a verbatim SEC excerpt.
Shao-Hsiang Shih was elected as Director at VITASPRING BIOMEDICAL CO. LTD..
“Effective at 11:56 p.m. Pacific Time on September 7, 2026, Ssu-Chuan Lai, as the sole director then in office, elected Shao-Hsiang Shih to serve as a director of the Company, to hold office until the next annual meeting of stockholders and until his successor is duly elected and qualified, or until his earlier death, resignation or removal.”
Jing-Zhou Chen was appointed as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
“Effective at 11:57 p.m. Pacific Time on September 7, 2026, Dr. Ssu-Chuan Lai, as the sole director then in office, appointed Jing-Zhou Chen as the Company’s Chief Executive Officer, President, Chief Financial Officer, and Secretary, to serve at the pleasure of the Board and until his successor is duly appointed and qualified, or until his earlier death, resignation or removal.”
Ssu-Chuan Lai resigned as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
“Effective at 11:58 p.m. Pacific Time on September 7, 2026, immediately following the election of her successor as a director and the appointment of her successor officers as described in Items 5.02(c) and (d) below, Dr. Ssu-Chuan Lai resigned from her positions as Chairperson of the Board, Chief Executive Officer, President, Chief Financial Officer, and Secretary of the Company, and as a member of the Board.”
VITASPRING BIOMEDICAL CO. LTD. engaged JP Centurion & Partners PLT as its auditor.
“On August 19, 2025, the Board of Directors of VitaSpring Biomedical Co., Ltd. (the “Company”) approved the engagement of JP Centurion & Partners PLT (“JP Centurion”) as the Company’s independent registered public accounting firm, effective as of such date.”
TAAD LLP resigned as auditor of VITASPRING BIOMEDICAL CO. LTD..
“On August 5, 2025, TAAD LLP (“TAAD”) resigned as our independent registered public accounting firm, effective immediately.”
VITASPRING BIOMEDICAL CO. LTD. engaged TAAD LLP as its auditor.
“On January 24, 2023, our board of directors approved the engagement of TAAD LLP ("TAAD"), as the Company's new independent registered public accounting firm.”
Kho & Patel, Certified Public Accountants resigned as auditor of VITASPRING BIOMEDICAL CO. LTD..
“On January 17, 2023, Kho & Patel, Certified Public Accountants, ("Kho"), resigned as the independent registered public accounting firm of Vitaspring Biomedical Co. Ltd. (the "Company").”
Kao Cheng-Hsiang was appointed as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
“current secretary of the Company, Kao Cheng-Hsiang, was appointed CEO and retains his position as Secretary.”
Chu Pao-Chi resigned as Chief Executive Officer at VITASPRING BIOMEDICAL CO. LTD..
“Effective August 7, 2020, Chu Pao-Chi Chairman of the Board of Directors, and Chief Executive Officer of the Company, resigned his position as CEO”
Facts are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.